ALERT: Globe Advisor Client Management Changes
Client Center will be decommissioned December 31, 2018. Read More

ARROWHEAD PHARMACEUTICALS, INC.

Arrowhead Pharmaceuticals, Inc. is a biopharmaceutical company which develops novel drugs to treat intractable diseases primarily in the United States. The company's proprietary Dynamic Polyconjugate platform develops drugs based on the RNA interference mechanism which silences disease-causing genes. Its products include ARC-520, ARC-521, ARC-AAT, ARC-F12, ARC-HIF2 and ARC-LPA which are in different clinical trial phase. Arrowhead Pharmaceuticals, Inc., formerly known as Arrowhead Research Corporation, is headquartered in Pasadena, California.


Find Out More
 • Chart
 • News
 • Stock today
 • Price Reports
 • Financial Reports
 • Price History
 • Estimate Reports
 • Estimate Snapshot
 • Add To Your Stocklist
 • View your Stocklist
Click here to print this page.
Symbol: ARWR
Exchange(s): Nasdaq Stock Market
Industry: Industrial Products (Electrical & Electronic)
5-Star Rating:
ANNUAL FINANCIALS
  Sep 30, 2017
12 Months
us$
Sep 30, 2016
12 Months
us$
Sep 30, 2015
12 Months
us$
3Yr.
Growth
% Change
Total Revenue ($000) 31,410 160 380 458.81
Earnings before Interest & Tax ($000) -34,380 -81,720 -91,940 N/A
Profit/Loss ($000) -34,380 -81,720 -91,940 N/A
Earnings per Share -0.47 -1.34 -1.60 N/A
Total Assets ($000) 104,020 128,180 132,270 -17.14
Dividends Per Share 0.00 0.00 0.00  
Return on Com. Equity -39.09 -79.87 -66.72  
Employees N/A N/A N/A  
 
Trailing 12 Month Results
  12 Months ended
Sep 30, 2018,us$
12 Months ended
Sep 30, 2017,us$
%Change
Total Revenue ($000) N/A 31,410 N/A
Profit/Loss ($000) N/A -34,380 N/A
Earnings per Share N/A -0.47 N/A
Dividends Per Share 0.00 0.00
Number of Shares 88,020,000 74,770,000  
 
COMPANY INFORMATION
Key Personnel
CEO: Douglass Given, Chairman of the Board of Direc
CFO: Christopher Anzalone, Chief Executive Officer; Presi
 
Contact Information
Address: 225 SOUTH LAKE AVENUE SUITE 1,
PASADENA,
CA,
91101
Phone: 626-304-3400
Fax: 626-304-3401
Web Address: www.arrowheadpharma.com
E-Mail : ir@arrowheadpharma.com
 
Incorporation: United States 
 
Securities: ARWR-Q
 
Top Companies in Electrical & Electronic (Selected by Assets)
Apple Sony Corp. IBM Corp.
Intel Cisco Systems Taiwan Semiconductor
Thermo Fisher Scientific Avago Technologies Canon Inc.
 


Zacks Investment Research Financial data is provided by Zacks Investment Research.
All information on this site is compiled by The Globe and Mail Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, The Globe and Mail Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor. Copyright © 2019 The Globe and Mail Inc. All rights reserved.

<